Product Description
Overall, the global therapeutic OSA device market was valued at $4.4 billion in 2023. This is expected to increase over the forecast period at a CAGR of 3.6% to reach nearly $5.6 billion.
Overall, the global sleep diagnostics device market was valued at over $362 million in 2023. This is expected to increase over the forecast period at a CAGR of 6.2% to reach $551 million.
This global market research spans over 70 countries and includes the global market for obstructive sleep apnea with the positive airway pressure device market and the sleep therapy interface market. In addition, the sleep diagnostic devices market is included with the polysomnography device market and the home respiratory polygraph device market.
MARKET DATA INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2030, and Historical Data to 2020
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Therapeutic Obstructive Sleep Apnea Device Market Insights
Sleep Diagnostic Device Market Insights
Therapeutic Obstructive Sleep Apnea MARKET SHARE INSIGHTS
Philips Healthcare led the sleep diagnostics market, especially in polysomnography and home respiratory polygraphy, known for its Alice® and Stardust® II devices. However, in January 2024, Philips shifted its focus towards consumables, discontinuing several sleep product lines, including Alice® models.
Natus, ranking second, offered SleepWorks™, Embletta®, and NicoletOne™ for in-lab use, and Xltek® Trex™ and Embletta® MPR for home tests. Known for its high-quality build and extensive diagnostic tools, Natus made strides with its durable Embletta® Gold for home use and the comprehensive Embletta®X100.
ResMed’s ApneaLink™ stands out for its automatic analysis features and global distribution strength, potentially increasing its market share. In partnership with Verily, ResMed initiated the digital Sleep Apnea Study 2 in 2018, integrating sleep therapy research seamlessly into participants’ daily routines.
Sleep Diagnostic Device MARKET SHARE INSIGHTS
In 2023, ResMed topped the therapeutic OSA device market, excelling in sleep therapy interfaces and PAP devices, including APAP, BiPAP, and CPAP models like the S9™, AutoSet™, VPAP™, AirCurve™, AirSense™, and AirMini™. Its latest, the AirSense 11™ and 10™, build on the S9™ with an innovative feature: the Air Solutions connected care platform, enabling instant wireless data transmission for timely patient care.
Philips Healthcare, known for its strong brand in OSA therapy and sleep diagnostics, leads with its Alice® series in polysomnography. The REMstar® Pro CPAP device offers advanced therapy tracking, while its successor, the PR System One REMstar®, auto-adjusts therapy settings. Despite a strong product line, including various masks, Philips has faced challenges due to product recalls.
Fisher & Paykel’s CPAP devices, under ICON™ and SleepStyle™, feature sensors for detecting and adjusting to breathing irregularities, aiding patient comfort and sleep continuity. The company offers a diverse range of masks, including the innovative F&P Evora™ with CapFit™ headgear, designed for ease of use and effective therapy, launched in 2020.
Market Segmentation Summary
- Therapeutic Obstructive Sleep Apnea Devices Market – Segmented By:
- Device Type: Positive Airway Pressure (Continuous, Auto-Titrating, Bi-Level), Sleep Therapy Interface (Nasal Mask, Full-Face Mask, Nasal Pillow/Alternative Interface)
- Sleep Diagnostic Devices Market – Segmented By:
- Device Type: Polysomnography, Home Respiratory Polygraphy
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Mongolia, Malaysia, Myanmar, New Zealand, Philippines, Pakistan, Singapore, South Korea, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2023 |
| Forecast | 2024-2030 |
| Historical Data | 2020-2023 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
